ASX - By Stock
|
RAD Biotech |
Re:
RAD media and Publications
|
|
colinjb56
|
176 |
69K |
2 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
176
|
69K
|
2
|
|
ASX - By Stock
|
RAD Biotech |
Re:
RAD media and Publications
|
|
colinjb56
|
176 |
69K |
0 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
176
|
69K
|
0
|
|
ASX - By Stock
|
IME |
Re:
Ann: Trading Halt
|
|
colinjb56
|
9 |
1.9K |
0 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
9
|
1.9K
|
0
|
|
ASX - By Stock
|
IME |
Re:
Ann: 2023 Q4 Quarterly Activities Report & Appendix 4C
|
|
colinjb56
|
5 |
1.6K |
2 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
5
|
1.6K
|
2
|
|
ASX - By Stock
|
RAD |
Re:
Ann: EGM Presentation
|
|
colinjb56
|
13 |
4.7K |
5 |
18/08/23 |
18/08/23 |
ASX - By Stock
|
13
|
4.7K
|
5
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
colinjb56
|
14 |
6.9K |
9 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
14
|
6.9K
|
9
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
colinjb56
|
6 |
2.3K |
3 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
6
|
2.3K
|
3
|
|
ASX - By Stock
|
RAD |
Re:
News: RAD Radiopharm Theranostics Says U.S. FDA Granted Orphan Drug Designation To GA68-TRIVEHEXIN
|
|
colinjb56
|
73 |
23K |
0 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
73
|
23K
|
0
|
|
ASX - By Stock
|
IME |
Re:
Ann: IMEXHS wins new contract with Grupo Avidanti
|
|
colinjb56
|
9 |
2.3K |
3 |
27/04/23 |
27/04/23 |
ASX - By Stock
|
9
|
2.3K
|
3
|
|
ASX - By Stock
|
IME |
Re:
Ann: IMEXHS Investor Update
|
|
colinjb56
|
26 |
5.4K |
2 |
23/03/23 |
23/03/23 |
ASX - By Stock
|
26
|
5.4K
|
2
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Security Class Reinstatement to Quotation
|
|
colinjb56
|
2 |
794 |
1 |
28/11/22 |
28/11/22 |
ASX - By Stock
|
2
|
794
|
1
|
|
ASX - By Stock
|
RAD |
Re:
Ann: AGM Presentation
|
|
colinjb56
|
11 |
3.6K |
1 |
18/11/22 |
18/11/22 |
ASX - By Stock
|
11
|
3.6K
|
1
|
|
ASX - By Stock
|
RAD |
Re:
Ann: AGM Presentation
|
|
colinjb56
|
11 |
3.6K |
1 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
11
|
3.6K
|
1
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Entitlement Offer - Extension of Retail Offer
|
|
colinjb56
|
13 |
4.5K |
0 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
13
|
4.5K
|
0
|
|
ASX - By Stock
|
IME |
Re:
Ann: 2022 Q3 Quarterly Activities Report and Appendix 4C
|
|
colinjb56
|
14 |
6.3K |
3 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
14
|
6.3K
|
3
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Entitlement Offer - Letter to Eligible Retail Shareholders
|
|
colinjb56
|
12 |
4.8K |
0 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
12
|
4.8K
|
0
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Entitlement Offer - Letter to Eligible Retail Shareholders
|
|
colinjb56
|
12 |
4.8K |
1 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
12
|
4.8K
|
1
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Quarterly Activities/App 4C Business Update
|
|
colinjb56
|
14 |
7.4K |
3 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
14
|
7.4K
|
3
|
|
ASX - By Stock
|
RAD |
Re:
Ann: RAD agreement with NorthStar for supply of Actinium-225
|
|
colinjb56
|
52 |
13K |
3 |
26/10/22 |
26/10/22 |
ASX - By Stock
|
52
|
13K
|
3
|
|
ASX - By Stock
|
RAD |
Re:
Ann: RAD agreement with NorthStar for supply of Actinium-225
|
|
colinjb56
|
52 |
13K |
0 |
26/10/22 |
26/10/22 |
ASX - By Stock
|
52
|
13K
|
0
|
|
ASX - By Stock
|
RAD |
Re:
Ann: RAD agreement with NorthStar for supply of Actinium-225
|
|
colinjb56
|
52 |
13K |
0 |
26/10/22 |
26/10/22 |
ASX - By Stock
|
52
|
13K
|
0
|
|
ASX - By Stock
|
RAD |
Re:
Ann: RAD agreement with NorthStar for supply of Actinium-225
|
|
colinjb56
|
52 |
13K |
1 |
26/10/22 |
26/10/22 |
ASX - By Stock
|
52
|
13K
|
1
|
|
ASX - By Stock
|
RAD |
Re:
Ann: RAD agreement with NorthStar for supply of Actinium-225
|
|
colinjb56
|
52 |
13K |
0 |
26/10/22 |
26/10/22 |
ASX - By Stock
|
52
|
13K
|
0
|
|
ASX - By Stock
|
RAD |
Re:
Ann: RAD agreement with NorthStar for supply of Actinium-225
|
|
colinjb56
|
52 |
13K |
1 |
26/10/22 |
26/10/22 |
ASX - By Stock
|
52
|
13K
|
1
|
|
ASX - By Stock
|
RAD |
Re:
Ann: RAD agreement with NorthStar for supply of Actinium-225
|
|
colinjb56
|
52 |
13K |
2 |
26/10/22 |
26/10/22 |
ASX - By Stock
|
52
|
13K
|
2
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Successful Completion of Institutional Entitlement Offer
|
|
colinjb56
|
24 |
6.6K |
5 |
24/10/22 |
24/10/22 |
ASX - By Stock
|
24
|
6.6K
|
5
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Successful Completion of Institutional Entitlement Offer
|
|
colinjb56
|
24 |
6.6K |
1 |
24/10/22 |
24/10/22 |
ASX - By Stock
|
24
|
6.6K
|
1
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Successful Completion of Institutional Entitlement Offer
|
|
colinjb56
|
24 |
6.6K |
5 |
20/10/22 |
20/10/22 |
ASX - By Stock
|
24
|
6.6K
|
5
|
|
ASX - By Stock
|
IME |
Re:
Ann: Application for quotation of securities - IME
|
|
colinjb56
|
9 |
2.7K |
1 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
9
|
2.7K
|
1
|
|
ASX - By Stock
|
IME |
Re:
Ann: Trading halt
|
|
colinjb56
|
30 |
8.1K |
2 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
30
|
8.1K
|
2
|
|
ASX - By Stock
|
M7T |
Re:
M7T July report
|
|
colinjb56
|
18 |
8.0K |
1 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
18
|
8.0K
|
1
|
|
ASX - By Stock
|
RAD |
Re:
Paul Hopper IP opportunists CHM VS RAD
|
|
colinjb56
|
28 |
11K |
3 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
28
|
11K
|
3
|
|
ASX - By Stock
|
IME |
Re:
Ann: Trading halt
|
|
colinjb56
|
30 |
8.1K |
4 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
30
|
8.1K
|
4
|
|
ASX - By Stock
|
IME |
Re:
Ann: IMEXHS wins new contract with Colombia's National Police
|
|
colinjb56
|
11 |
3.0K |
1 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
11
|
3.0K
|
1
|
|
ASX - By Stock
|
IME |
Re:
Ann: Appendix 3G
|
|
colinjb56
|
2 |
804 |
0 |
19/07/22 |
19/07/22 |
ASX - By Stock
|
2
|
804
|
0
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Investor webinar - RAD adds brain tumor technology
|
|
colinjb56
|
51 |
18K |
4 |
18/07/22 |
18/07/22 |
ASX - By Stock
|
51
|
18K
|
4
|
|
ASX - By Stock
|
IME |
Re:
Ann: 2022 Q1 Quarterly Activities Report and Appendix 4C
|
|
colinjb56
|
25 |
6.3K |
3 |
25/06/22 |
25/06/22 |
ASX - By Stock
|
25
|
6.3K
|
3
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Investor webinar - RAD adds brain tumor technology
|
|
colinjb56
|
51 |
18K |
3 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
51
|
18K
|
3
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Mach7 Signs contract renewal with a total value of A$2.8m
|
|
colinjb56
|
20 |
8.1K |
0 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
20
|
8.1K
|
0
|
|
ASX - By Stock
|
RAD |
Re:
Ann: RAD adds Brain Tumor Technology to Portfolio
|
|
colinjb56
|
10 |
3.7K |
11 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
10
|
3.7K
|
11
|
|
ASX - By Stock
|
IME |
Re:
Ann: FY22 Outlook Update
|
|
colinjb56
|
22 |
8.7K |
2 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
22
|
8.7K
|
2
|
|
ASX - By Stock
|
M7T |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
colinjb56
|
25 |
14K |
0 |
09/05/22 |
09/05/22 |
ASX - By Stock
|
25
|
14K
|
0
|
|
ASX - By Stock
|
IME |
Re:
Ann: Appendix 3Y - Douglas Lingard
|
|
colinjb56
|
11 |
2.5K |
2 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
11
|
2.5K
|
2
|
|
ASX - By Stock
|
IME |
Re:
Ann: IMEXHS Strategy Presentation
|
|
colinjb56
|
48 |
13K |
1 |
21/03/22 |
21/03/22 |
ASX - By Stock
|
48
|
13K
|
1
|
|
ASX - By Stock
|
M7T |
Re:
Share price increasing on low volumes
|
|
colinjb56
|
12 |
4.8K |
0 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
12
|
4.8K
|
0
|
|
ASX - By Stock
|
IME |
Re:
Ann: IMEXHS Reports FY21 Financial Results
|
|
colinjb56
|
21 |
6.7K |
2 |
02/03/22 |
02/03/22 |
ASX - By Stock
|
21
|
6.7K
|
2
|
|
ASX - By Stock
|
IME |
Re:
Ann: IMEXHS Reports FY21 Financial Results
|
|
colinjb56
|
21 |
6.7K |
0 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
21
|
6.7K
|
0
|
|
ASX - By Stock
|
IME |
Re:
Ann: 2021 Q4 Quarterly Activities Report and Appendix 4C
|
|
colinjb56
|
21 |
6.1K |
2 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
21
|
6.1K
|
2
|
|
ASX - By Stock
|
IME |
Re:
News: IME Imexhs Ltd Says Qtrly Revenue Of A$4.7M Was Up 11%
|
|
colinjb56
|
9 |
2.2K |
2 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
9
|
2.2K
|
2
|
|
ASX - By Stock
|
IME |
Re:
News: IME Imexhs Ltd Says Qtrly Revenue Of A$4.7M Was Up 11%
|
|
colinjb56
|
9 |
2.2K |
2 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
9
|
2.2K
|
2
|
|